Thompson Davis & CO. Inc. Makes New Investment in Myomo, Inc. (NYSEAMERICAN:MYO)

Thompson Davis & CO. Inc. purchased a new position in shares of Myomo, Inc. (NYSEAMERICAN:MYO) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 28,150 shares of the company’s stock, valued at approximately $181,000.

Other large investors also recently bought and sold shares of the company. Barclays PLC purchased a new position in shares of Myomo in the 3rd quarter valued at $36,000. Jane Street Group LLC purchased a new position in shares of Myomo in the 3rd quarter valued at $65,000. Calamos Advisors LLC purchased a new position in shares of Myomo in the 4th quarter valued at $189,000. XTX Topco Ltd purchased a new position in shares of Myomo in the 3rd quarter valued at $149,000. Finally, Palumbo Wealth Management LLC purchased a new position in shares of Myomo in the 4th quarter valued at $242,000. Hedge funds and other institutional investors own 44.99% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. HC Wainwright reissued a “buy” rating and issued a $7.50 target price on shares of Myomo in a research note on Wednesday, November 13th. Ascendiant Capital Markets raised their target price on shares of Myomo from $8.50 to $9.00 and gave the company a “buy” rating in a research note on Tuesday, November 12th. Finally, Craig Hallum raised their price target on shares of Myomo from $7.00 to $9.00 and gave the company a “buy” rating in a report on Friday, December 13th.

Myomo Stock Down 2.7 %

MYO opened at $5.74 on Friday. Myomo, Inc. has a twelve month low of $2.51 and a twelve month high of $7.17.

Myomo Company Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.